Rafferty Asset Management’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-3,019
| Closed | -$251K | – | 1139 |
|
|
2025
Q3 | $251K | Sell |
3,019
-317
| -10% | -$22.9K | ﹤0.01% | 1027 |
|
|
2025
Q2 | $245K | Sell |
3,336
-2,591
| -44% | -$188K | ﹤0.01% | 1017 |
|
|
2025
Q1 | $677K | Buy |
5,927
+21
| +0.4% | +$1.28K | ﹤0.01% | 815 |
|
|
2024
Q4 | $298K | Sell |
5,906
-5,606
| -49% | -$294K | ﹤0.01% | 1026 |
|
|
2024
Q3 | $533K | Buy |
11,512
+69
| +0.6% | +$2.45K | ﹤0.01% | 920 |
|
|
2024
Q2 | $372K | Sell |
11,443
-4,117
| -26% | -$113K | ﹤0.01% | 1021 |
|
|
2024
Q1 | $392K | Buy |
15,560
+7,151
| +85% | +$169K | ﹤0.01% | 1019 |
|
|
2023
Q4 | $273K | Buy |
+8,409
| New | +$231K | ﹤0.01% | 1040 |
|
|
2022
Q4 | – | Sell |
-8,637
| Closed | -$221K | – | 1130 |
|
|
2022
Q3 | $221K | Sell |
8,637
-2,434
| -22% | -$65.1K | ﹤0.01% | 1078 |
|
|
2022
Q2 | $263K | Buy |
+11,071
| New | +$241K | ﹤0.01% | 960 |
|
|
2022
Q1 | – | Sell |
-10,913
| Closed | -$216K | – | 1234 |
|
|
2021
Q4 | $216K | Buy |
+10,913
| New | +$221K | ﹤0.01% | 1212 |
|
|
2021
Q1 | – | Sell |
-10,110
| Closed | -$264K | – | 1162 |
|
|
2020
Q4 | $264K | Buy |
+10,110
| New | +$213K | ﹤0.01% | 871 |
|
|
2020
Q3 | – | Sell |
-12,185
| Closed | -$205K | – | 965 |
|
|
2020
Q2 | $205K | Buy |
+12,185
| New | +$171K | ﹤0.01% | 924 |
|
|
2019
Q3 | – | Sell |
-25,568
| Closed | -$285K | – | 810 |
|
|
2019
Q2 | $285K | Sell |
25,568
-23,237
| -48% | -$259K | 0.01% | 754 |
|
|
2019
Q1 | $573K | Buy |
+48,805
| New | +$606K | 0.01% | 642 |
|
|
2018
Q2 | – | Sell |
-59,201
| Closed | -$974K | – | 660 |
|
|
2018
Q1 | $974K | Buy |
+59,201
| New | +$1.1M | 0.01% | 464 |
|
Other funds holding CORT
ISL
PA
